During drug development, understanding Phase I metabolism is essential for predicting the pharmacokinetics and potential toxicological effects of new drugs. Identifying the metabolites formed and their activity is crucial for assessing the safety and efficacy of a drug candidate. This phase helps in optimizing dosing regimens and identifying any potential drug-drug interactions.
